Meropenem
| Structural formula | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | 
||||||||||||||||||||||
| General | ||||||||||||||||||||||
| Non-proprietary name | Meropenem | |||||||||||||||||||||
| other names | 
 Latin : Meropenemum  | 
|||||||||||||||||||||
| Molecular formula | C 17 H 25 N 3 O 5 S | |||||||||||||||||||||
| Brief description | 
 white to pale yellow, crystalline powder (meropenem trihydrate)  | 
|||||||||||||||||||||
| External identifiers / databases | ||||||||||||||||||||||
  | 
||||||||||||||||||||||
| Drug information | ||||||||||||||||||||||
| ATC code | ||||||||||||||||||||||
| Drug class | ||||||||||||||||||||||
| Mechanism of action | ||||||||||||||||||||||
| properties | ||||||||||||||||||||||
| Molar mass | 383.46 g · mol -1 | |||||||||||||||||||||
| solubility | 
 sparingly soluble in water, very sparingly soluble in dilute ethanol , practically insoluble in acetone and diethyl ether (trihydrate)  | 
|||||||||||||||||||||
| safety instructions | ||||||||||||||||||||||
  | 
||||||||||||||||||||||
| Toxicological data | ||||||||||||||||||||||
| As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . | ||||||||||||||||||||||
Meropenem is a drug that belongs to the group of carbapenems and is sold by AstraZeneca .
pharmacology
See carbapenems , unlike imipenem , meropenem is stable to dehydropeptidase I.
Spectrum of activity
The spectrum of activity is greater in the area of gram-negative bacteria compared to imipenem .
Side effects
The side effects largely correspond to those of penicillins and cephalosporins . However, epileptic seizures can also occur.
Trade names
Meronem (D, CH), Optinem (A)
Web links
- FDA label for Merrem® iv from March 27, 2008 (PDF; 198 kB)
 
Individual evidence
- ^ A b The Merck Index : An Encyclopedia of Chemicals, Drugs, and Biologicals , 14th Edition (Merck & Co., Inc.), Whitehouse Station, NJ, USA, 2006, p. 1018; ISBN 978-0-911910-00-1 .
 - ↑ There is not yet a harmonized classification for this substance . What is shown is a label of (4R, 5S, 6S) -3 - [[(3S, 5S) -5 - [(dimethylamino) carbonyl] -3-pyrrolidinyl] thio] -6 - [(1R ) -1-hydroxyethyl] -4-methyl-7-oxo-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid in the Classification and Labeling Inventory of the European Chemicals Agency (ECHA), accessed on July 8 2020.
 - ↑ Entry on meropenem in the ChemIDplus database of the United States National Library of Medicine (NLM), accessed on July 8, 2020.